March 2021 updates to the website
18 March 2021
The website has now been updated following March's LSCMMG
The following guidelines have been added/updated:
Linezolid Info Sheet - New
Neuropathic Pain Guidance - Updated (Pending changes, QA and sign off)
Gender dysphoria Information Sheet - Update
Requests from a private GIC to prescribe hormone therapy or blockade in gender dysphoria - Position Statement - New
The following Items have been updated and added to the website following the latest Joint Committee of CCGs (JCCCG) Meeting:
Domperidone - As a galactagogue for birth mothers and mothers of adopted babies
Semaglutide Tablets - for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise
Galcanezumab - for preventing migraine (TA659)
liraglutide - for managing overweight and obesity (TA664)
Upadacitinib - for treating severe rheumatoid arthritis (TA665)
Brolucizumab - for treating wet age-related macular degeneration
Amiodarone Tablets - Arrhythmias
Dronedarone - Treatment of non-permanent atrial fibrillation (NICE TA197)
The following Items will be updated and added to the website following the next Joint Committee of CCGs (JCCCG) Meeting:
Naldemedine - for treating moderate to severe rheumatoid arthritis (TA672)
Filgotinib - for treating moderate to severe rheumatoid arthritis (TA676)
Dapagliflozin - for treating chronic heart failure with reduced ejection fraction (TA679)